Last deal

$2M

Amount

Seed

Stage

01.12.2019

Date

1

all rounds

$2M

Total amount

General

About Company
Canary detects cancers and diseases early through breath analysis using biomarkers, nanosensors, and AI-powered software.

Industry

Sector :

Subsector :

Also Known As

canary, canary health tech

founded date

01.01.2018

Number of employees

Company Type

For Profit

Last funding type

Seed

IPO status

Private

Description

Their 3-minute digital test analyzes exhaled breath in real-time, providing immediate results without the need for sample processing or shipping. This cloud-based solution enables disease surveillance and is designed for use in primary healthcare settings with minimal infrastructure and training. Canary aims to improve treatment outcomes and help patients achieve personalized health goals by combining ingestible computing, cloud computing, and mobile digital dispensing technology. Their focus is on developing diagnostic products and services that enable real-time disease detection using AI and nanotechnology.
Contacts